Investigations of survivin: The past, present and future

Chun Hei Antonio Cheung, Li Ting Cheng, Kwang Yu Chang, Huang Hui Chen, Jang Yang Chang

Research output: Contribution to journalArticlepeer-review

52 Citations (Scopus)


Survivin is a member of the inhibitors-ofapoptosis protein (IAPs) family. It promotes cell survival through interference with multiple cell cycle-related proteins such as INCENP and Aurora B kinase. Survivin also inhibits cell death through interference with both caspase-dependent and -independent cell apoptosis. Interestingly, recent evidence suggests that survivin may also play a role in the regulation of cancer cell autophagy. At the clinical level, studies on clinical specimens have shown that survivin expression is up-regulated in various human cancers and its up-regulation is associated with tumour resistance to both chemotherapy and radiation therapy. On the basis of these findings, survivin has been proposed as an attractive target for new anti-cancer interventions. However, despite the role that survivin plays in cancer cell survival and anti-drug response, the development of survivin inhibitors is relatively slow as compared to other therapeutic inhibitors for cancer treatment. In this review, the relationships between survivin expression and the causation of drug resistance in cancers are re-addressed. This review also summarizes the recent development of survivin inhibitors for clinical usage.

Original languageEnglish
Pages (from-to)952-961
Number of pages10
JournalFrontiers in Bioscience
Issue number3
Publication statusPublished - Jan 2011
Externally publishedYes


  • BIRC5
  • Cancer
  • Hsp90
  • IAPs
  • Review
  • Survivin
  • YM155

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)


Dive into the research topics of 'Investigations of survivin: The past, present and future'. Together they form a unique fingerprint.

Cite this